Does a Positive Rivalta Test Always Mean FIP

Feline Infectious Peritonitis (FIP) remains one of the most challenging diseases in feline medicine. The Rivalta test is frequently used as a rapid diagnostic tool to help identify FIP, but controversy surrounds its specificity and sensitivity. This article explores the biology of FIP, the mechanics of the Rivalta test, its diagnostic accuracy, alternative diagnoses, and how veterinarians should approach effusive disease in cats.

Feline Infectious Peritonitis: Basics

FIP is caused by a mutation of feline coronavirus (FCoV), resulting in a fatal systemic inflammatory disease in cats. It primarily affects young cats and those in multicat households or shelters. There are two clinical forms: the effusive (wet) form, with accumulation of fluids in body cavities, and the noneffusive (dry) form, which is more insidious and harder to diagnose.

FIP’s clinical presentation can include lethargy, fever, weight loss, anorexia, and fluid accumulation in the abdomen or chest. Unfortunately, diagnosis is difficult, as signs overlap with many other disorders. A definitive diagnosis usually necessitates histopathology or immunohistochemistry, highlighting the value of reliable noninvasive tests like the Rivalta test.

The Rivalta Test: Procedure and Principles

The Rivalta test, developed for human medicine, is straightforward and inexpensive. It’s used to differentiate exudates (such as those seen in FIP) from transudates (as seen with heart or liver disease). The procedure involves adding a few drops of the suspect fluid to a solution of distilled water and acetic acid (or vinegar). If the fluid forms a cloudy drop or precipitate that doesn’t dissolve, it’s considered positive. If it disperses softly, it’s negative.

The basis for a positive reaction is the high protein content and presence of inflammatory mediators in exudative effusions, which are typical for FIP. However, other diseases can also produce high-protein effusions, complicating interpretation.

Diagnostic Value: Sensitivity and Specificity

Studies have evaluated the Rivalta test’s reliability for FIP diagnosis. Reported sensitivity ranges from 91% to 98%, while specificity is lower (66%–86%). This means most cats with FIP will have a positive Rivalta test, but a significant number of cats with other diseases can also test positive.

A 2012 study by Hartmann et al. revealed that although the test was valuable, false positives occurred with lymphomas, bacterial infections, and other systemic diseases. The Rivalta test should be interpreted alongside clinical signs, effusion analysis, and additional laboratory tests.

Other Causes of Positive Rivalta Test

Many conditions produce inflammatory effusions.

Lymphoma: Cats with abdominal or thoracic lymphoma may develop exudative effusions.

Bacterial Peritonitis/Pleuritis: Infections from ruptured organs can produce high-protein fluid.

Pancreatitis: Inflammation extending to the peritoneum causes exudative effusion.

Chylothorax: Less commonly, the lymphatic fluid may have elevated protein levels.

Because these and other diseases can yield a positive result, the test is best used as part of a diagnostic algorithm rather than a standalone tool.

FIP Mimics: Clinical Evaluation

Veterinarians should differentiate FIP from its “mimics”—diseases that cause similar signs.

Clinical History: Exposure risks, age, vaccination status, and environment provide clues. FIP is common in young, shelter cats.

Complete Blood Count & Chemistry: FIP typically presents with moderate anemia, high globulins, and low albumin. But similar changes occur with other inflammatory diseases.

Effusion Analysis: FIP fluid is straw-colored, viscous, with high protein (>3.5g/dL) and low cell count. Yet, overlapping characteristics occur in neoplastic or infectious conditions.

Imaging: Ultrasound and radiographs help localize effusion and identify masses, organ rupture, or foreign bodies.

Coronavirus Antibody Testing: High titers support exposure, but aren’t specific for FIP.

PCR Testing: Detects viral RNA, but FCoV is common and not always pathogenic. Advanced PCR targeting mutated virus is promising but not universally available.

Integrated Diagnostic Approach

The gold standard for FIP diagnosis is histopathology, yet clinical reality often dictates a combination of tests to form a presumptive diagnosis. The Rivalta test becomes more useful when combined with a compatible history, clinical signs, and supporting lab results.

Serial Testing: Repeat analysis over days can help follow disease progression.

Multiple Effusion Sites: FIP often produces fluid in both chest and abdomen, which is less typical of other diseases.

Response to Therapy: FIP does not respond to antibiotics or steroids alone; improvement hints at another cause.

False Positives: Clinical Impact

Over-reliance on the Rivalta test can lead to misdiagnosis. False positives may prompt unwarranted euthanasia in cases that could respond to therapy, such as bacterial peritonitis or neoplasia. It’s critical to communicate with cat owners that the Rivalta test is one piece of the puzzle.

New Horizons in FIP Diagnostics

Recent advances include RT-PCR tests to detect viral mutations and immunocytochemistry. In regions where these are unavailable, the Rivalta test remains part of the toolkit but should be contextualized. Point-of-care tests for FIP and analysis of biomarkers like alpha-1-acid glycoprotein may improve diagnostic accuracy in the future.

Clinical Case Example

A three-year-old male DSH cat presents with ascites and fever. The Rivalta test is positive. However, ultrasound reveals a pancreatic mass, and cytology confirms pancreatitis. The cat improves with supportive care, confirming that a positive Rivalta test does not equal FIP.

Practical Recommendations for Veterinarians

Use the Rivalta test as a preliminary screen, not a diagnosis.

Always correlate with clinical signs, effusion analysis, and additional tests.

Consider alternative diagnoses—neoplasia, infectious diseases, trauma—in every positive case.

Communicate clearly with cat owners about the limitations of the test.

Knowledge Gaps and Future Directions

Despite decades of use, the Rivalta test lacks absolute specificity for FIP. Studies with larger populations and standardized protocols may yield better data. Veterinarians should stay informed about new developments in the diagnosis and treatment of FIP.

References

1. Hartmann, K., et al. (2012). "Diagnostic comparison of the Rivalta test and other laboratory tests in cats with effusions." Journal of Feline Medicine and Surgery, 14(2), 100-107.

2. Felten, S., & Hartmann, K. (2019). "Diagnosis of feline infectious peritonitis: A review of the current literature." Viruses, 11(12), 1069.

3. Kipar, A., & Meli, M. L. (2014). "Feline infectious peritonitis: still an enigma?" Veterinary Pathology, 51(2), 505-526.

4. Fischer, Y., et al. (2011). "Detection of feline coronavirus RNA in abdominal effusions by RT-PCR as a diagnostic tool for feline infectious peritonitis." Journal of Feline Medicine and Surgery, 13(2), 143-148.

5. Tasker, S. (2018). "Diagnosis of feline infectious peritonitis: Update on current and future diagnostic options." Veterinary Medicine: Research and Reports, 9, 87-96.

6. Addie, D. D., et al. (2020). "Feline coronavirus infections: ABCD guidelines on prevention and management." Journal of Feline Medicine and Surgery, 22(7), 630-655.

7. Stranieri, A., et al. (2018). "The diagnostic sensitivity of the Rivalta test in cats with effusions of different etiologies." Veterinary Clinical Pathology, 47(4), 879-887.

8. Erles, K., & Brownlie, J. (2013). "Feline coronavirus: Pathogenesis of feline infectious peritonitis." Journal of Feline Medicine and Surgery, 15(7), 497-504.

9. Riemer, F., et al. (2016). "Alpha-1 acid glycoprotein as a marker for feline infectious peritonitis." Journal of Feline Medicine and Surgery, 18(6), 399-406.